Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment.
Zhou W, Huang Z, Wu C, Lu S, Fu C, Ye P, Tan Y, Wu Z, Fan X, Zhang J, Guo S, Jia S, Stalin A, Wang H, Zhang X, Wang M, Wu J. Zhou W, et al. Among authors: ye p. J Ethnopharmacol. 2021 Oct 28;279:114386. doi: 10.1016/j.jep.2021.114386. Epub 2021 Jul 3. J Ethnopharmacol. 2021. PMID: 34224810
High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
Liu X, Wu Y, Zhang Y, Bu D, Wu C, Lu S, Huang Z, Song Y, Zhao Y, Guo F, Ye P, Fu C, Shen L, Zhang J, Wang H, Duan X, Wu J. Liu X, et al. Among authors: ye p. Front Oncol. 2021 Sep 17;11:747300. doi: 10.3389/fonc.2021.747300. eCollection 2021. Front Oncol. 2021. PMID: 34604090 Free PMC article.
A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
Wu C, Huang ZH, Meng ZQ, Fan XT, Lu S, Tan YY, You LM, Huang JQ, Stalin A, Ye PZ, Wu ZS, Zhang JY, Liu XK, Zhou W, Zhang XM, Wu JR. Wu C, et al. Chin Med. 2021 Nov 22;16(1):121. doi: 10.1186/s13020-021-00534-y. Chin Med. 2021. PMID: 34809653 Free PMC article.
Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology.
Zhang J, Huang Z, Liu X, Wu C, Zhou W, Ye P, Stalin A, Lu S, Tan Y, Wu Z, Fan X, Zhang X, Wang M, Li B, Cheng G, Mou Y, Wu J. Zhang J, et al. Among authors: ye p. Biomed Res Int. 2022 Mar 18;2022:6213865. doi: 10.1155/2022/6213865. eCollection 2022. Biomed Res Int. 2022. PMID: 35342754 Free PMC article.
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
Liu X, Bai M, Li H, Ye P, Duan X, Wu C, Huang Z, Lu S, Zhang J, Zhao Z, Guo F, You R, Qin W, Wang W, Han A, Shen L, Wang Y, Zhao Z, Luo H, Wu J. Liu X, et al. Among authors: ye p. Front Immunol. 2022 Oct 31;13:965342. doi: 10.3389/fimmu.2022.965342. eCollection 2022. Front Immunol. 2022. PMID: 36389835 Free PMC article.
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
Guo S, Liu X, Zhang J, Huang Z, Ye P, Shi J, Stalin A, Wu C, Lu S, Zhang F, Gao Y, Jin Z, Tao X, Huang J, Zhai Y, Shi R, Guo F, Zhou W, Wu J. Guo S, et al. Among authors: ye p. Comput Biol Med. 2023 Jul;161:107066. doi: 10.1016/j.compbiomed.2023.107066. Epub 2023 May 27. Comput Biol Med. 2023. PMID: 37263064
1,918 results